quinazolines has been researched along with Leishmaniasis in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ankur, V; Kumar, SP; Kumar, SS; Mahender, T; Pankaj, W | 1 |
| Agrawal, RK; Kumar, D; Sahu, A | 1 |
| Croft, SL; Sanderson, L; Yardley, V | 1 |
| Choudhary, MI; Ghouri, N; Khan, KM; Perveen, S; Saad, SM | 1 |
| Belluti, F; Bolognesi, ML; Bongarzone, S; Cavalli, A; Lizzi, F; Piazzi, L | 1 |
3 review(s) available for quinazolines and Leishmaniasis
| Article | Year |
|---|---|
Some Scaffolds as Anti-leishmanial Agents: A Review.
Topics: Antiprotozoal Agents; Humans; Leishmania; Leishmaniasis; Leishmaniasis, Visceral; Quinazolines | 2022 |
Antileishmanial Drug Discovery: Synthetic Methods, Chemical Characteristics, and Biological Potential of Quinazolines and its Derivatives.
Topics: Animals; Antiprotozoal Agents; Drug Discovery; Humans; Leishmania; Leishmaniasis; Quinazolines | 2017 |
Complementary medicinal chemistry-driven strategies toward new antitrypanosomal and antileishmanial lead drug candidates.
Topics: Animals; Antiprotozoal Agents; Chemistry, Pharmaceutical; Combinatorial Chemistry Techniques; Drug Design; Drug Discovery; Humans; Leishmania; Leishmaniasis; Quinazolines; Trypanocidal Agents; Trypanosoma; Trypanosomiasis | 2010 |
2 other study(ies) available for quinazolines and Leishmaniasis
| Article | Year |
|---|---|
Activity of anti-cancer protein kinase inhibitors against Leishmania spp.
Topics: Animals; Antineoplastic Agents; Antiprotozoal Agents; Disease Models, Animal; Drug Repositioning; Indoles; Inhibitory Concentration 50; Lapatinib; Leishmania; Leishmaniasis; Mice, Inbred BALB C; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyrroles; Quinazolines; Sorafenib; Sunitinib; Treatment Outcome | 2014 |
4-Arylamino-6-nitroquinazolines: Synthesis and their activities against neglected disease leishmaniasis.
Topics: Antiprotozoal Agents; Dose-Response Relationship, Drug; Humans; Leishmania major; Leishmaniasis; Molecular Structure; Neglected Diseases; Parasitic Sensitivity Tests; Quinazolines; Structure-Activity Relationship | 2016 |